Cargando…
Circulating nucleic acids as biomarkers in breast cancer
During tumor development, tumor cells release their nucleic acids into the blood circulation. This process occurs by apoptotic and necrotic cell deaths along with active cell secretion, resulting in high levels of circulating DNA, mRNA, and microRNA in the blood of patients with breast cancer. As ci...
Autor principal: | Schwarzenbach, Heidi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3978696/ https://www.ncbi.nlm.nih.gov/pubmed/24090167 http://dx.doi.org/10.1186/bcr3446 |
Ejemplares similares
-
Circulating DNA as biomarker in breast cancer
por: Schwarzenbach, Heidi, et al.
Publicado: (2015) -
Circulating microRNAs: promising breast cancer biomarkers - authors' response
por: Roth, Carina, et al.
Publicado: (2011) -
Circulating and non-circulating proteins and nucleic acids as biomarkers and therapeutic molecules in ovarian cancer
por: Utkarsh, Kumar, et al.
Publicado: (2022) -
The current role of circulating biomarkers in non-muscle invasive bladder cancer
por: Rink, Michael, et al.
Publicado: (2019) -
Circulating Nucleic Acid-Based Biomarkers of Type 2 Diabetes
por: Padilla-Martinez, Felipe, et al.
Publicado: (2021)